299 related articles for article (PubMed ID: 21325519)
1. Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant.
Sydow A; Van der Jeugd A; Zheng F; Ahmed T; Balschun D; Petrova O; Drexler D; Zhou L; Rune G; Mandelkow E; D'Hooge R; Alzheimer C; Mandelkow EM
J Neurosci; 2011 Feb; 31(7):2511-25. PubMed ID: 21325519
[TBL] [Abstract][Full Text] [Related]
2. Spreading of Tau Protein Does Not Depend on Aggregation Propensity.
Rodrigues S; Anglada-Huguet M; Hochgräfe K; Kaniyappan S; Wegmann S; Mandelkow EM
J Mol Neurosci; 2023 Oct; 73(9-10):693-712. PubMed ID: 37606769
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD.
Sydow A; Hochgräfe K; Könen S; Cadinu D; Matenia D; Petrova O; Joseph M; Dennissen FJ; Mandelkow EM
Acta Neuropathol Commun; 2016 Feb; 4():17. PubMed ID: 26916334
[TBL] [Abstract][Full Text] [Related]
4. A novel transgenic mouse line with hippocampus-dominant and inducible expression of truncated human tau.
Gao Y; Wang Y; Lei H; Xu Z; Li S; Yu H; Xie J; Zhang Z; Liu G; Zhang Y; Zheng J; Wang JZ
Transl Neurodegener; 2023 Nov; 12(1):51. PubMed ID: 37950283
[TBL] [Abstract][Full Text] [Related]
5. Human Tau Aggregates Are Permissive to Protein Synthesis-Dependent Memory in
Vourkou E; Rouiz Ortega ED; Mahajan S; Mudher A; Skoulakis EMC
J Neurosci; 2023 Apr; 43(16):2988-3006. PubMed ID: 36868851
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of MTMR14 induced learning and memory impairments in 2-month-old C57 mice.
Feng Q; Li X; Liu R; Liu G; He Y; Li T
Neurosci Lett; 2024 Mar; 825():137700. PubMed ID: 38401642
[TBL] [Abstract][Full Text] [Related]
7. Correction: Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade.
Acquarone E; Argyrousi EK; van den Berg M; Gulisano W; Fà M; Staniszewski A; Calcagno E; Zuccarello E; D'Adamio L; Deng SX; Puzzo D; Arancio O; Fiorito J
Mol Neurodegener; 2024 Apr; 19(1):39. PubMed ID: 38685083
[No Abstract] [Full Text] [Related]
8. Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau.
Van der Jeugd A; Hochgräfe K; Ahmed T; Decker JM; Sydow A; Hofmann A; Wu D; Messing L; Balschun D; D'Hooge R; Mandelkow EM
Acta Neuropathol; 2012 Jun; 123(6):787-805. PubMed ID: 22532069
[TBL] [Abstract][Full Text] [Related]
9. Pro-aggregant Tau impairs mossy fiber plasticity due to structural changes and Ca(++) dysregulation.
Decker JM; Krüger L; Sydow A; Zhao S; Frotscher M; Mandelkow E; Mandelkow EM
Acta Neuropathol Commun; 2015 Apr; 3():23. PubMed ID: 25853683
[TBL] [Abstract][Full Text] [Related]
10. Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice.
Maeda S; Djukic B; Taneja P; Yu GQ; Lo I; Davis A; Craft R; Guo W; Wang X; Kim D; Ponnusamy R; Gill TM; Masliah E; Mucke L
EMBO Rep; 2016 Apr; 17(4):530-51. PubMed ID: 26931567
[TBL] [Abstract][Full Text] [Related]
11. Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau.
Hochgräfe K; Sydow A; Matenia D; Cadinu D; Könen S; Petrova O; Pickhardt M; Goll P; Morellini F; Mandelkow E; Mandelkow EM
Acta Neuropathol Commun; 2015 May; 3():25. PubMed ID: 25958115
[TBL] [Abstract][Full Text] [Related]
12. Propagation of tau pathology in a model of early Alzheimer's disease.
de Calignon A; Polydoro M; Suárez-Calvet M; William C; Adamowicz DH; Kopeikina KJ; Pitstick R; Sahara N; Ashe KH; Carlson GA; Spires-Jones TL; Hyman BT
Neuron; 2012 Feb; 73(4):685-97. PubMed ID: 22365544
[TBL] [Abstract][Full Text] [Related]
13. Microtubule-associated protein tau is essential for long-term depression in the hippocampus.
Kimura T; Whitcomb DJ; Jo J; Regan P; Piers T; Heo S; Brown C; Hashikawa T; Murayama M; Seok H; Sotiropoulos I; Kim E; Collingridge GL; Takashima A; Cho K
Philos Trans R Soc Lond B Biol Sci; 2014 Jan; 369(1633):20130144. PubMed ID: 24298146
[TBL] [Abstract][Full Text] [Related]
14. Identification of oligomers at early stages of tau aggregation in Alzheimer's disease.
Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Sarmiento J; Troncoso J; Jackson GR; Kayed R
FASEB J; 2012 May; 26(5):1946-59. PubMed ID: 22253473
[TBL] [Abstract][Full Text] [Related]
15. Neuropathological alterations in Alzheimer disease.
Serrano-Pozo A; Frosch MP; Masliah E; Hyman BT
Cold Spring Harb Perspect Med; 2011 Sep; 1(1):a006189. PubMed ID: 22229116
[TBL] [Abstract][Full Text] [Related]
16. Tau in physiology and pathology.
Wang Y; Mandelkow E
Nat Rev Neurosci; 2016 Jan; 17(1):5-21. PubMed ID: 26631930
[TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation in Alzheimer's disease.
Heneka MT; Carson MJ; El Khoury J; Landreth GE; Brosseron F; Feinstein DL; Jacobs AH; Wyss-Coray T; Vitorica J; Ransohoff RM; Herrup K; Frautschy SA; Finsen B; Brown GC; Verkhratsky A; Yamanaka K; Koistinaho J; Latz E; Halle A; Petzold GC; Town T; Morgan D; Shinohara ML; Perry VH; Holmes C; Bazan NG; Brooks DJ; Hunot S; Joseph B; Deigendesch N; Garaschuk O; Boddeke E; Dinarello CA; Breitner JC; Cole GM; Golenbock DT; Kummer MP
Lancet Neurol; 2015 Apr; 14(4):388-405. PubMed ID: 25792098
[TBL] [Abstract][Full Text] [Related]
18. Pathological tau disrupts ongoing network activity.
Menkes-Caspi N; Yamin HG; Kellner V; Spires-Jones TL; Cohen D; Stern EA
Neuron; 2015 Mar; 85(5):959-66. PubMed ID: 25704951
[TBL] [Abstract][Full Text] [Related]
19. Lost after translation: missorting of Tau protein and consequences for Alzheimer disease.
Zempel H; Mandelkow E
Trends Neurosci; 2014 Dec; 37(12):721-32. PubMed ID: 25223701
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
